Histogenics Corporation News - HSGX

Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer

BOSTON and JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today announced that...

Quarterly Report (10-q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Proxy Statement (definitive) (def 14a)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents Filed Pursuant to...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESS...

Securities Registration Statement (simplified Form) (s-3/a)

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 &nbs...

Securities Registration Statement (simplified Form) (s-3)

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the...

Amended Current Report Filing (8-k/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 &nbs...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...

Statement of Ownership (sc 13g)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Histogenics Corporation (HSGX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

HSGX News

Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer

Quarterly Report (10-q)

Proxy Statement (definitive) (def 14a)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

Notice of Effectiveness (effect)

Securities Registration Statement (simplified Form) (s-3/a)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Securities Registration Statement (simplified Form) (s-3)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Statement of Changes in Beneficial Ownership (4)

HSGX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Histogenics Corporation (HSGX) News

Histogenics Corporation (HSGX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

HSGX News

Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer

Quarterly Report (10-q)

Proxy Statement (definitive) (def 14a)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

Notice of Effectiveness (effect)

Securities Registration Statement (simplified Form) (s-3/a)

Statement of Changes in Beneficial Ownership (4)

Current Report Filing (8-k)

Securities Registration Statement (simplified Form) (s-3)

Amended Current Report Filing (8-k/a)

Current Report Filing (8-k)

Statement of Ownership (sc 13g)

Statement of Changes in Beneficial Ownership (4)

HSGX Discussion

Your Recent History